TechNavio's analysts forecast the
Strategic Overview of Global Preventable Vaccine Market to grow at a CAGR of
8.99 percent over the period 2012-2016. One of the key factors contributing to
this market growth is the increase in demand for vaccination. The Strategic
Overview of Global Preventable Vaccine market has also been witnessing the
trend of increase in market consolidation. However, the emergence of regional
players could pose a challenge to the growth of this market.
TechNavio's report, the Strategic
Overview of Global Preventable Vaccine Market 2012-2016, has been prepared
based on an in-depth market analysis with inputs from industry experts. The
report covers Americas, and the EMEA and APAC regions; it also covers the
Strategic Overview of Global Preventable Vaccine Market landscape and its
growth prospects in the coming years. The report also includes a discussion of
the key vendors operating in this market.
Key vendors dominating this space
include GlaxoSmithKline plc. Sanofi Pasteur SA, Merck & Co. Inc., Novartis
AG, Pfizer Inc., Emergent BioSolutions Inc .
Key questions answered in this
report:
* What will the market size be in
2016 and at what will be the growth rate?
* What are key market trends?
* What is driving this market?
* What are the challenges to market
growth?
* Who are the key vendors in this
market space?
* What are the market opportunities
and threats faced by key vendors?
* What are the strengths and
weaknesses of each of these key vendors?
You can request one free hour of our
analysts time when you purchase this market report. Details provided within the
report.
To order this report:
Email: support@researchonglobalmarkets.com
US:
+1 866 325 7446
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com
RELATED VIDEO:
No comments:
Post a Comment